A vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) was found to be safe, well-tolerated and induced a neutralizing antibody response in adult volunteers, according to newly published results from a Phase 1 clinical trial. The vaccine candidate was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health.
- Read more about Vaccine for Rare but Deadly Mosquito-Borne Viruses Shows Promise in Clinical Trial
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/vaccine-for-rare-but-deadly-mosquito-borne-viruses-shows-promise-in-clinical-trial
No comments:
Post a Comment